On October 13, 2022, the Issuer notified the Nasdaq Global Select Market (“NASDAQ”) that the Merger had been completed, and requested that NASDAQ suspend trading of Shares on NASDAQ prior to the opening of trading on October 13, 2022. The Issuer also requested that NASDAQ file with the U.S. Securities and Exchange Commission (the “SEC”) a notification of removal from listing and registration on Form 25 to effect the delisting of all Shares from NASDAQ and the deregistration of such shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As a result, Shares will no longer be listed on NASDAQ.
In addition, the Issuer intends to file a certification on Form 15 with the SEC requesting the termination of registration of all Shares under Section 12(g) of the Exchange Act and the suspension of the Issuer’s reporting obligations under Section 13 of the Exchange Act with respect to all Shares.
Changes to Board of Directors and Officers
At, and conditioned on the occurrence of, the Effective Time, Deborah G. Ellinger, Paul Fonteyne, Sandra L. Helton, Philip A. Laskawy, Mark J. Manoff, Edward M. McNamara, Steven Paladino, Sandra Peterson, Ravi Sachdev and Sharon Wienbar each resigned from their positions as members of the board of directors of the Issuer and from any and all committees of the board of directors on which they served. Pursuant to the terms of the Merger Agreement, at the Effective Time, Benjamin Wolin and Matthew J. Foulston, who were directors of Merger Sub immediately before the Effective Time, were elected as the directors of the Surviving Corporation. The officers of the Issuer immediately prior to the Effective Time continued as officers of the Surviving Corporation.
Amendments to Articles of Incorporation of Bylaws
Pursuant to the terms of the Merger Agreement, at the Effective Time, the Issuer’s Second Amended and Restated Certificate of Incorporation, as in effect immediately prior to the Effective Time, was amended and restated in its entirety.
Pursuant to the terms of the Merger Agreement, at the Effective Time, the Issuer’s Amended and Restated Bylaws, as in effect immediately prior to the Effective Time, was amended and restated in their entirety.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a)-(b) As of the date hereof, following the Contribution and the Merger, the Reporting Persons did not directly hold any Shares. Through their indirect interests in Parent, the Reporting Persons may be deemed to beneficially own and share the power to vote and dispose of shares of common stock of the Surviving Corporation.
(c) Except as otherwise described in Item 4 of this Schedule 13D, each of the Reporting Persons reports that neither it, nor to its knowledge, any other person named in Schedule A of this Schedule 13D, has effected any transactions in Shares in the past 60 days.
(d) None of the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares.
(e) On October 13, 2022, each of the Reporting Persons ceased to be the beneficial owners of more than 5% of the outstanding Shares.
5